# Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects

> **NCT03258762** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 14 (actual)

## Conditions studied

- Toxoplasmosis

## Interventions

- **DRUG:** Pyrimethamine
- **DRUG:** Calcium folinate

## Key facts

- **NCT ID:** NCT03258762
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-25
- **Primary completion:** 2017-11-19
- **Final completion:** 2017-11-19
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03258762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03258762, "Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03258762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*